Physician

Zachary Ingersoll, DO

According to 2025 Medicare claims, Zachary Ingersoll, DO (NPI: 1023538956) practices dermatology in the Grand Junction, CO market, with the plurality of this provider's patient population coming from Mesa, CO. This provider's primary affiliated billing organization is EPIPHANY DERMATOLOGY OF COLORADO, LLC (NPI: 1992297469; TIN: 371899636) and primary practice location at 81505-1590.

Ingersoll's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 681 traditional Medicare patients, billed 6,936 HCPCS/CPT codes, and received $386,529 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 876 prescription claims across 355 beneficiaries totaling $603,240 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 62 records totaling $1,386. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,603 to $603,240. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$197K$394K2021 Medicare payment: $175,747 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $353,124 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $394,387 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $386,529 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213236,617$175,747
202270911,160$353,124
20238147,427$394,387
20246816,936$386,529

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$302K$603K2017 Drug cost: $1,603 (USD; Tot_Drug_Cst)2021 Drug cost: $5,892 (USD; Tot_Drug_Cst)2022 Drug cost: $171,620 (USD; Tot_Drug_Cst)2023 Drug cost: $334,821 (USD; Tot_Drug_Cst)2024 Drug cost: $603,240 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171424$1,603
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021126208$5,892
2022312611$171,620
2023413918$334,821
2024355876$603,240

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks190242$432
11102Biopsy of related skin growth, first growth146173$66
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more390560$59
17000Destruction of precancer skin growth, 1 growth328511$39
17003Destruction of precancer skin growth, 2-14 growths2291,110$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab842,338$328,704
Cyltezo(Cf) PenAdalimumab-Adbm17476$129,700
Humira(Cf) PenAdalimumab12336$96,695
TacrolimusTacrolimus27805$2,746
FluorouracilFluorouracil421,139$2,745

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.62$1,386Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Zachary Ingersoll, DO?

Tedicare shows public-source Medicare data for Zachary Ingersoll, DO (NPI 1023538956), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zachary Ingersoll, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Zachary Ingersoll, DO?

Zachary Ingersoll, DO is linked to EPIPHANY DERMATOLOGY OF COLORADO, LLC (billing NPI 1992297469) in the available physician profile data.

Does Zachary Ingersoll, DO have Open Payments data?

Zachary Ingersoll, DO has 62 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.